HUMORAL FACTORS IN INFLAMMATION
炎症中的体液因素
基本信息
- 批准号:3338174
- 负责人:
- 金额:$ 21.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-05-08 至 1994-04-30
- 项目状态:已结题
- 来源:
- 关键词:aminoacid analyzer anaphylatoxins antibody formation cell type cellular immunity chemical structure function complement complement receptor crosslink guinea pigs high performance liquid chromatography humoral immunity inflammation iodine laboratory mouse laboratory rabbit laboratory rat macrophage monocyte protein biosynthesis radionuclides radiotracer receptor binding receptor expression tissue /cell culture
项目摘要
The anaphylatoxins mediate spasmogenic, chemotactic and
immunoregulatory responses primarily through specific receptor
interactions with granulocytes and monocytes. The primary targets
of the ligand C5a in man are believed to be the neutrophil and the
monocyte (macrophage). Involvement of other cell types such as
platelets, lymphocytes, endothelial cells and mast cells may occur
as an indirect consequence of granulocyte or monocyte activation
and secondary mediator release. Evidence exists that a C5a
receptor of approximately 40,000 kDa occurs on the human neutrophil
surface and that this membrane component has an affinity for the
ligand of 1-3 nM Kd. The human neutrophil has no receptor for the
C3a anaphylatoxin.
This proposal concerns both C5a and C3a receptors on monocytes
(macrophages). Preliminary evidence indicates that monocytes and
tissue macrophages from human and animal sources have C3a and C5a
receptors. Using chemical cross-linking techniques to visualize
these membrane components, a C3a binding protein of approximately
1000,000 kDa and a C5a binding protein of approximately 40,000 kDa
were observed. We plan to isolate these receptors, characterize
them in terms of carbohydrate content and solubility. Monospecific
immune reagents will be prepared to study functional attributes of
the C5a receptor on macrophages and for use in purification of the
receptor in quantities adequate for partial sequence analysis.
Probes designed from protein sequence analysis will be used for
complete molecular analysis of the membrane component. We have
observed that transformed murine macrophage cell lines express C5a
receptors. When these cell lines are injected intraperitoneally
into mice, tumors are grown that contain large quantities of the
macrophages having markedly enhanced number of C5a receptors (i.e.
upregulated from membrane components desired). We plan to use this
discovery to advantage in isolation and characterization of the
macrophage chemotactic (C5a) receptor. A biologic, biochemical
and molecular analysis of the anaphylatoxic receptors on monocytes
and macrophages should lead to a better understanding of the role
that humoral factors play in modulating immune and inflammatory
responses. Circulating monocytes and tissue macrophages appear to
play a pivotal role in host defense mechanisms. Early events in
target cell activation are elicited by factors such as
anaphylatoxins and bacterial products indicating that they
represent activators of major biologic consequence.
过敏毒素介导痉挛性、趋化性和
主要通过特定受体的免疫调节反应
与粒细胞和单核细胞的相互作用。 主要目标
据信,人类配体 C5a 是中性粒细胞,
单核细胞(巨噬细胞)。 其他细胞类型的参与,例如
血小板、淋巴细胞、内皮细胞和肥大细胞可能发生
作为粒细胞或单核细胞激活的间接结果
和次级介体释放。 有证据表明 C5a
人类中性粒细胞上存在约 40,000 kDa 的受体
表面并且该膜成分对
1-3 nM Kd 的配体。 人类中性粒细胞没有受体
C3a过敏毒素。
该提案涉及单核细胞上的 C5a 和 C3a 受体
(巨噬细胞)。 初步证据表明单核细胞和
人类和动物来源的组织巨噬细胞含有 C3a 和 C5a
受体。 使用化学交联技术可视化
这些膜成分,大约是 C3a 结合蛋白
1000,000 kDa 和约 40,000 kDa 的 C5a 结合蛋白
被观察到。 我们计划分离这些受体,表征
它们的碳水化合物含量和溶解度。 单特异性
将制备免疫试剂来研究功能属性
巨噬细胞上的 C5a 受体并用于纯化
受体的数量足以进行部分序列分析。
根据蛋白质序列分析设计的探针将用于
膜成分的完整分子分析。 我们有
观察到转化的小鼠巨噬细胞系表达 C5a
受体。 当这些细胞系被腹腔注射时
小鼠体内长出的肿瘤含有大量的
巨噬细胞的 C5a 受体数量显着增加(即
从所需的膜成分上调)。 我们计划使用这个
发现有利于分离和表征
巨噬细胞趋化 (C5a) 受体。 生物、生化
单核细胞过敏毒性受体的分子分析
和巨噬细胞应该可以更好地理解其作用
体液因子在调节免疫和炎症中发挥作用
回应。 循环单核细胞和组织巨噬细胞似乎
在宿主防御机制中发挥着关键作用。 早期事件发生在
靶细胞激活是由以下因素引起的
过敏毒素和细菌产物表明它们
代表主要生物学后果的激活剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TONY E HUGLI其他文献
TONY E HUGLI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TONY E HUGLI', 18)}}的其他基金
相似海外基金
Altered Treg Differentiation in ALD: A Novel Role for Anaphylatoxins C3a and C5a
ALD 中 Treg 分化的改变:过敏毒素 C3a 和 C5a 的新作用
- 批准号:
9795355 - 财政年份:2018
- 资助金额:
$ 21.51万 - 项目类别:
The role of the anaphylatoxins C3a and C5a in the pathogenesis of experimental allergic asthma
过敏毒素C3a和C5a在实验性过敏性哮喘发病机制中的作用
- 批准号:
256784565 - 财政年份:2014
- 资助金额:
$ 21.51万 - 项目类别:
Research Grants
Anaphylatoxins and epithelial cell biology
过敏毒素和上皮细胞生物学
- 批准号:
401125-2010 - 财政年份:2010
- 资助金额:
$ 21.51万 - 项目类别:
University Undergraduate Student Research Awards
The role of the anaphylatoxins C3a and C5a in the pathogenesis of experimental allergic asthma (A21)
过敏毒素 C3a 和 C5a 在实验性过敏性哮喘发病机制中的作用 (A21)
- 批准号:
126279373 - 财政年份:2009
- 资助金额:
$ 21.51万 - 项目类别:
CRC/Transregios
Complement protection and anaphylatoxins in neuroinflammation
神经炎症中的补体保护和过敏毒素
- 批准号:
7911418 - 财政年份:2007
- 资助金额:
$ 21.51万 - 项目类别:
Complement protection and anaphylatoxins in neuroinflammation
神经炎症中的补体保护和过敏毒素
- 批准号:
7670725 - 财政年份:2007
- 资助金额:
$ 21.51万 - 项目类别:
Complement protection and anaphylatoxins in neuroinflammation
神经炎症中的补体保护和过敏毒素
- 批准号:
7406829 - 财政年份:2007
- 资助金额:
$ 21.51万 - 项目类别:
Evolutionary Origins and Novel Roles of Anaphylatoxins and their Receptors in Innate Immune Reactions of Teleost Fish
过敏毒素及其受体在硬骨鱼先天免疫反应中的进化起源和新作用
- 批准号:
0417078 - 财政年份:2004
- 资助金额:
$ 21.51万 - 项目类别:
Continuing grant
Cytokines as regulators of the biologic efffects of anaphylatoxins (A 04)
细胞因子作为过敏毒素生物效应的调节剂 (A 04)
- 批准号:
5274382 - 财政年份:2001
- 资助金额:
$ 21.51万 - 项目类别:
Collaborative Research Centres
Development of a novel therapeutic approach to the renal injury by the control of anaphylatoxins.
通过控制过敏毒素开发一种新的肾损伤治疗方法。
- 批准号:
13557085 - 财政年份:2001
- 资助金额:
$ 21.51万 - 项目类别:
Grant-in-Aid for Scientific Research (B)